{
    "clinical_study": {
        "@rank": "138070", 
        "acronym": "DETB", 
        "arm_group": {
            "arm_group_label": "Phenelzine treatment", 
            "arm_group_type": "Experimental", 
            "description": "Subjects will undergo a PET and MRI scan before and after the treatment."
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine if monoamine oxidase B (MAO-B) total distribution\n      volume (VT), after phenelzine treatment and if so to what extent."
        }, 
        "brief_title": "Detecting Central and Peripheral Biomarkers in MDD", 
        "completion_date": {
            "#text": "March 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Major Depressive Disorder", 
        "condition_browse": {
            "mesh_term": [
                "Depressive Disorder", 
                "Depression", 
                "Depressive Disorder, Major"
            ]
        }, 
        "detailed_description": {
            "textblock": "Subjects will receive a PET and MRI scan before and after treatment with phenelzine."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  18-80 years of age\n\n          -  good physical health\n\n          -  Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) diagnosis of current\n             major depressive episode (MDE)\n\n          -  DSM-IV diagnosis of major depressive disorder (MDD) verified by SCID for DSM-IV and a\n             psychiatric consultation\n\n          -  greater than 17 on the 17 item HDRS (Hamilton Depression Rating Scale).\n\n          -  history of non-response to several different antidepressant classes\n\n        Exclusion Criteria:\n\n          -  herbal, drug or medication use (that affect CNS function)\n\n          -  suicide attempts\n\n          -  drug or medication use within eight weeks (+5 half lives of medication)\n\n          -  history of substance abuse or any neurotoxin use\n\n          -  history of psychotic symptoms\n\n          -  history of central nervous system (CNS) medical illness\n\n          -  current substance abuse\n\n          -  test positive on pregnancy test (for women)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "15", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 28, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02153281", 
            "org_study_id": "DETB-071-13"
        }, 
        "intervention": {
            "arm_group_label": "Phenelzine treatment", 
            "description": "Subjects will have a PET and MRI scan before and after treatment with phenelzine.", 
            "intervention_name": "phenelzine treatment", 
            "intervention_type": "Other"
        }, 
        "intervention_browse": {
            "mesh_term": "Phenelzine"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Depression", 
            "Positron Emission Tomography (PET)", 
            "MAO-B"
        ], 
        "lastchanged_date": "June 2, 2014", 
        "link": {
            "description": "Information about research at the Centre for Addiction and Mental Health", 
            "url": "http://www.camh.ca/research"
        }, 
        "location": {
            "contact": {
                "last_name": "Laura Miler", 
                "phone": "416-535-8501", 
                "phone_ext": "34386"
            }, 
            "facility": {
                "address": {
                    "city": "Toronto", 
                    "country": "Canada", 
                    "state": "Ontario", 
                    "zip": "M5T 1R8"
                }, 
                "name": "Center for Addiction and Mental Health"
            }, 
            "investigator": {
                "last_name": "Jeffrey Meyer, MD PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "1", 
        "official_title": "Detecting Central and Peripheral Biomarkers in Major Depressive Disorder (MDD)", 
        "overall_contact": {
            "last_name": "Laura Miler", 
            "phone": "416.535.8501", 
            "phone_ext": "34386"
        }, 
        "overall_official": {
            "affiliation": "Research Imaging Centre, Centre for Addiction and Mental Health", 
            "last_name": "Jeffrey H. Meyer, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Canada: Health Canada", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "MAO-B VT levels measured with PET in MDE secondary to MDD", 
            "safety_issue": "No", 
            "time_frame": "8 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02153281"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Centre for Addiction and Mental Health", 
            "investigator_full_name": "Jeff Meyer", 
            "investigator_title": "Head Neurochemical Imaging in Mood Disorders", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Centre for Addiction and Mental Health", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre for Addiction and Mental Health", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2014", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}